TP53 and inflammatory bowel disease: In the carcinogenic process in IBD-CRC, mutation and loss of the APC gene are less frequent and occur in a later phase of the dysplasia–carcinoma sequence, whereas mutation and loss of P53 are more frequent and likely to occur in an earlier phase [32].